A common haplotype at the dopamine transporter gene 5′ region is associated with attention‐deficit/hyperactivity disorder

The dopamine transporter (DAT) is the major site of methylphenidate action, which is one of the main drugs used to treat attention‐deficit/hyperactivity disorder (ADHD). Most association studies with ADHD focused in a VNTR at the 3′‐untranslated region of the gene (3′UTR) presenting conflicting results. However, the most common explanation to inconsistent results is variable linkage disequilibrium with an adjacent functional variant, just a few number of DAT1 studies have reported LD structure across the gene. In this study, we screened 16 polymorphisms across the DAT1 gene to understand LD structure in a Brazilian sample of families with ADHD probands and to verify if there were evidence for a biased transmission of alleles and haplotypes from parents to their 243 children with ADHD. In the DSM‐IV combined subtype, we observed a preferential transmission of the haplotype A/C/C/C/A derived from five SNPs (rs2550948, rs11564750, rs261759, rs2652511, rs2975223) in 5′ region (P corrected = 0.018) and no association with any allele/haplotype at the 3′ region of the gene, including the 3′ VNTR and the VNTR of intron 8. These results suggest a role for the promoter region in ADHD susceptibility and that allele heterogeneity should be highly considered in DAT1 gene association studies highlighting the importance of this gene in the genetics of the disorder. © 2008 Wiley‐Liss, Inc.

[1]  J. Granneman,et al.  Characterization of the 5'-flanking region of the human dopamine transporter gene. , 1999, Brain research. Molecular brain research.

[2]  I. Waldman,et al.  Two dopamine genes related to reports of childhood retrospective inattention and conduct disorder symptoms , 2001, Molecular Psychiatry.

[3]  M. Bannon The dopamine transporter: role in neurotoxicity and human disease. , 2005, Toxicology and applied pharmacology.

[4]  S. Faraone,et al.  Linkage analysis of attention deficit hyperactivity disorder , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[5]  P L Pearson,et al.  A whole-genome scan in 164 Dutch sib pairs with attention-deficit/hyperactivity disorder: suggestive evidence for linkage on chromosomes 7p and 15q. , 2003, American journal of human genetics.

[6]  P. Gorwood,et al.  Meta-analysis of family-based association studies between the dopamine transporter gene and attention deficit hyperactivity disorder , 2005, Psychiatric genetics.

[7]  P. Gorwood,et al.  Lack of association of the dopamine transporter gene in a French ADHD sample , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[8]  E. Eskin,et al.  Identification of additional variants within the human dopamine transporter gene provides further evidence for an association with bipolar disorder in two independent samples , 2006, Molecular Psychiatry.

[9]  Do Young Yoon,et al.  Association of the DAT1 polymorphism with attention deficit hyperactivity disorder (ADHD): A family‐based approach , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[10]  S. Nelson,et al.  Collaborative analysis of DRD4 and DAT genotypes in population-defined ADHD subtypes. , 2005, Journal of Child Psychology and Psychiatry and Allied Disciplines.

[11]  I. Waldman,et al.  Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity. , 1998, American journal of human genetics.

[12]  P. Riederer,et al.  The human dopamine transporter gene: the 5′-flanking region reveals five diallelic polymorphic sites in a Caucasian population sample , 2001, Neuroscience Letters.

[13]  S. Nelson,et al.  No evidence of linkage or linkage disequilibrium between DAT1 and attention deficit hyperactivity disorder in a large sample. , 1999, Psychiatric genetics.

[14]  M. Gill,et al.  Linkage disequilibrium mapping at DAT1, DRD5 and DBH narrows the search for ADHD susceptibility alleles at these loci , 2003, Molecular Psychiatry.

[15]  J Sergeant,et al.  The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes , 2006, Molecular Psychiatry.

[16]  David Coghill,et al.  The genetics of attention-deficit/hyperactivity disorder , 2009, Expert review of neurotherapeutics.

[17]  M. Gill,et al.  Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism , 1997, Molecular Psychiatry.

[18]  Lin He,et al.  Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD). , 2006, Human molecular genetics.

[19]  J. Kelsoe,et al.  Promoter and intronic variants affect the transcriptional regulation of the human dopamine transporter gene. , 2003, Genomics.

[20]  Michael Murias,et al.  Dopamine genes and ADHD , 2000, Neuroscience & Biobehavioral Reviews.

[21]  S. Faraone,et al.  Molecular genetics of attention deficit hyperactivity disorder. , 2010, The Psychiatric clinics of North America.

[22]  Deborah C. Mash,et al.  Common Human 5′ Dopamine Transporter (SLC6A3) Haplotypes Yield Varying Expression Levels In Vivo , 2006, Cellular and Molecular Neurobiology.

[23]  J. Buitelaar,et al.  DAT1, DRD4, and DRD5 polymorphisms are not associated with ADHD in Dutch families , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[24]  Henrik,et al.  A high-density SNP linkage scan with 142 combined subtype ADHD sib pairs identifies linkage regions on chromosomes 9 and 16 , 2008, Molecular Psychiatry.

[25]  Gerome Breen,et al.  A common haplotype of the dopamine transporter gene associated with attention-deficit/hyperactivity disorder and interacting with maternal use of alcohol during pregnancy. , 2006, Archives of general psychiatry.

[26]  R. Mark Wightman,et al.  Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter , 1996, Nature.

[27]  M. Bannon,et al.  The human dopamine transporter gene: gene organization, transcriptional regulation, and potential involvement in neuropsychiatric disorders , 2001, European Neuropsychopharmacology.

[28]  A. Kouzmenko,et al.  Intronic sequences are involved in neural targeting of human dopamine transporter gene expression. , 1997, Biochemical and biophysical research communications.

[29]  B. Franke,et al.  Confirmation that a specific haplotype of the dopamine transporter gene is associated with combined-type ADHD. , 2007, The American journal of psychiatry.

[30]  Pak Sham,et al.  A meta‐analysis of association studies between the 10‐repeat allele of a VNTR polymorphism in the 3′‐UTR of dopamine transporter gene and attention deficit hyperactivity disorder , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[31]  C. Francks,et al.  Attention Deficit Hyperactivity Disorder: Fine Mapping Supports Linkage to 5p13, 6q12, 16p13, and 17p11 , 2022 .

[32]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[33]  T. Perneger What's wrong with Bonferroni adjustments , 1998, BMJ.

[34]  H. Najmabadi,et al.  No association between the DAT1 10‐repeat allele and ADHD in the Iranian population , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[35]  B. Horta,et al.  The worldwide prevalence of ADHD: a systematic review and metaregression analysis. , 2007, The American journal of psychiatry.

[36]  A. Heath,et al.  No association of the dopamine transporter gene 3' VNTR polymorphism with ADHD subtypes in a population sample of twins. , 2001, American journal of medical genetics.

[37]  J. Rapoport,et al.  Attention-Deficit/Hyperactivity Disorder in a Population Isolate: Linkage to Loci at 4q13.2, 5q33.3, 11q22, and 17p11 , 2022 .

[38]  S. Purcell,et al.  The dopamine transporter gene is associated with attention deficit hyperactivity disorder in a Taiwanese sample , 2003, Molecular Psychiatry.

[39]  R. Joober,et al.  Dopamine genes and attention-deficit hyperactivity disorder: a review. , 2003, Journal of psychiatry & neuroscience : JPN.

[40]  M. Gill,et al.  Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children , 1999, Molecular Psychiatry.

[41]  X Li,et al.  Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. , 1992, Genomics.

[42]  M. Simsek,et al.  The VNTR polymorphism in the human dopamine transporter gene: improved detection and absence of association of VNTR alleles with attention-deficit hyperactivity disorder. , 2006, Genetic testing.

[43]  R. Rodriguiz,et al.  Aberrant responses in social interaction of dopamine transporter knockout mice , 2004, Behavioural Brain Research.

[44]  L. Rohde,et al.  A promoter polymorphism (−839 C > T) at the dopamine transporter gene is associated with attention deficit/hyperactivity disorder in Brazilian children , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[45]  L. Rohde,et al.  Attention-deficit hyperactivity disorder: a study of association with both the dopamine transporter gene and the dopamine D4 receptor gene. , 2001, American journal of medical genetics.

[46]  N J Cox,et al.  Association of attention-deficit disorder and the dopamine transporter gene. , 1995, American journal of human genetics.

[47]  W. Ewens,et al.  Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). , 1993, American journal of human genetics.

[48]  K Konrad,et al.  A genome-wide scan for attention-deficit/hyperactivity disorder in 155 German sib-pairs , 2006, Molecular Psychiatry.

[49]  K. Lesch,et al.  Association and linkage of allelic variants of the dopamine transporter gene in ADHD , 2007, Molecular Psychiatry.

[50]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[51]  A. Thapar,et al.  No support for association between the dopamine transporter (DAT1) gene and ADHD , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[52]  Xin Xu,et al.  Implementing a unified approach to family‐based tests of association , 2000, Genetic epidemiology.

[53]  C. Yiannoutsos,et al.  Association of the dopamine beta hydroxylase gene with attention deficit hyperactivity disorder: Genetic analysis of the Milwaukee longitudinal study , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[54]  C. Cusin,et al.  Dopamine transporter haplotype and attention-deficit hyperactivity disorder , 2005, Molecular Psychiatry.

[55]  C. Carlson,et al.  Dopamine transporter (SLC6A3) 5′ region haplotypes significantly affect transcriptional activity in vitro but are not associated with Parkinson's disease , 2005, Pharmacogenetics and genomics.

[56]  C. Francks,et al.  Pooled genome-wide linkage data on 424 ADHD ASPs suggests genetic heterogeneity and a common risk locus at 5p13 , 2006, Molecular Psychiatry.

[57]  M. Owen,et al.  A family-based and case-control association study of the dopamine D4 receptor gene and dopamine transporter gene in attention deficit hyperactivity disorder , 2000, Molecular Psychiatry.

[58]  Rebecca F. Halperin,et al.  Genome-wide linkage analysis of ADHD using high-density SNP arrays: novel loci at 5q13.1 and 14q12 , 2008, Molecular Psychiatry.

[59]  W. Roberts,et al.  Sequence variation in the 3′‐untranslated region of the dopamine transporter gene and attention‐deficit hyperactivity disorder (ADHD) , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[60]  J. Swanson,et al.  Subtypes versus severity differences in attention-deficit/hyperactivity disorder in the Northern Finnish Birth Cohort. , 2007, Journal of the American Academy of Child and Adolescent Psychiatry.